YU197387A - Process for producing izophamide-liophilizate - Google Patents

Process for producing izophamide-liophilizate

Info

Publication number
YU197387A
YU197387A YU01973/87A YU197387A YU197387A YU 197387 A YU197387 A YU 197387A YU 01973/87 A YU01973/87 A YU 01973/87A YU 197387 A YU197387 A YU 197387A YU 197387 A YU197387 A YU 197387A
Authority
YU
Yugoslavia
Prior art keywords
liophilizate
izophamide
producing
ifosfamide
weight
Prior art date
Application number
YU01973/87A
Other languages
English (en)
Inventor
D Sauerbier
U P Dammann
O Isaac
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of YU197387A publication Critical patent/YU197387A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Amplifiers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Control Of El Displays (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Indole Compounds (AREA)
YU01973/87A 1986-10-31 1987-10-30 Process for producing izophamide-liophilizate YU197387A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3637089 1986-10-31

Publications (1)

Publication Number Publication Date
YU197387A true YU197387A (en) 1988-12-31

Family

ID=6312873

Family Applications (1)

Application Number Title Priority Date Filing Date
YU01973/87A YU197387A (en) 1986-10-31 1987-10-30 Process for producing izophamide-liophilizate

Country Status (25)

Country Link
EP (1) EP0265812B1 (cg-RX-API-DMAC7.html)
JP (1) JPS63159319A (cg-RX-API-DMAC7.html)
KR (1) KR900003491B1 (cg-RX-API-DMAC7.html)
AT (1) ATE55250T1 (cg-RX-API-DMAC7.html)
AU (1) AU598602B2 (cg-RX-API-DMAC7.html)
CA (1) CA1314231C (cg-RX-API-DMAC7.html)
DD (1) DD262582A5 (cg-RX-API-DMAC7.html)
DE (1) DE3764235D1 (cg-RX-API-DMAC7.html)
DK (1) DK169308B1 (cg-RX-API-DMAC7.html)
EG (1) EG18333A (cg-RX-API-DMAC7.html)
ES (1) ES2017982B3 (cg-RX-API-DMAC7.html)
FI (1) FI87140C (cg-RX-API-DMAC7.html)
GE (1) GEP19971025B (cg-RX-API-DMAC7.html)
GR (1) GR3000708T3 (cg-RX-API-DMAC7.html)
HU (1) HU197987B (cg-RX-API-DMAC7.html)
IL (1) IL84312A (cg-RX-API-DMAC7.html)
IN (1) IN168119B (cg-RX-API-DMAC7.html)
LV (1) LV10051B (cg-RX-API-DMAC7.html)
MX (1) MX8958A (cg-RX-API-DMAC7.html)
NO (1) NO873860L (cg-RX-API-DMAC7.html)
PT (1) PT86032B (cg-RX-API-DMAC7.html)
RU (1) RU1836079C (cg-RX-API-DMAC7.html)
UA (1) UA11075A (cg-RX-API-DMAC7.html)
YU (1) YU197387A (cg-RX-API-DMAC7.html)
ZA (1) ZA878183B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0334083B1 (de) * 1988-03-19 1991-07-24 ASTA Pharma Aktiengesellschaft Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
WO1995007083A1 (en) * 1993-09-10 1995-03-16 F.H. Faulding & Co. Limited Ifosfamide lyophilisate composition
DE19529057B4 (de) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamid-Lyophilisat-Zubereitungen
ES2253877T3 (es) * 1998-03-03 2006-06-01 SHIONOGI & CO., LTD. Composiciones farmaceuticas que contienen el inhibidor de fosfolipasa((3-(2-amino-1,2-dioxoetil)-2-etil-1-(fenilmetil)-1h-indol-4-il)oxi)acetato de sodio.
AU2003276689B2 (en) * 2002-09-05 2009-04-09 Bharat Serums And Vaccines Ltd. Liquid stable composition of oxazaphosphorine with mesna
KR101066181B1 (ko) * 2002-12-02 2011-09-20 바라트 쎄럼스 앤드 백신스 리미티드 비경구 투여용 아이포스파마이드 조성물 및 이의 제조방법
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
KR101412296B1 (ko) * 2006-09-29 2014-06-25 인파 에스. 에이. 약제학적 조성물용 포장 시스템과 정맥 투여용 키트
CN105900385B (zh) * 2014-12-04 2019-08-27 华为技术有限公司 在数据通信网中的负载分配

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
DE2750207A1 (de) * 1977-05-09 1978-11-16 Walton J Smith Gefriergetrocknete zusammensetzungen, insbesondere gefriergetrocknete pharmazeutische praeparate und verfahren zu deren herstellung
DE3279834D1 (en) * 1981-12-31 1989-08-31 Asta Pharma Ag 4-sulfido-oxaza phosphorines and their use in the treatment of cancer, and in immunosuppression
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide

Also Published As

Publication number Publication date
EP0265812A1 (de) 1988-05-04
CA1314231C (en) 1993-03-09
GEP19971025B (en) 1997-04-06
GR3000708T3 (en) 1991-10-10
IN168119B (cg-RX-API-DMAC7.html) 1991-02-09
PT86032B (pt) 1990-08-31
ES2017982B3 (es) 1991-03-16
DK569687D0 (da) 1987-10-30
IL84312A (en) 1991-11-21
PT86032A (de) 1987-11-01
DK169308B1 (da) 1994-10-10
HUT44932A (en) 1988-05-30
FI87140C (fi) 1992-12-10
LV10051A (lv) 1994-05-10
LV10051B (en) 1995-06-20
FI874727L (fi) 1988-05-01
DE3764235D1 (de) 1990-09-13
ZA878183B (en) 1988-05-02
JPS63159319A (ja) 1988-07-02
HU197987B (en) 1989-07-28
DK569687A (da) 1988-05-01
RU1836079C (ru) 1993-08-23
DD262582A5 (de) 1988-12-07
FI874727A0 (fi) 1987-10-27
NO873860L (no) 1988-05-02
IL84312A0 (en) 1988-03-31
UA11075A (uk) 1996-12-25
FI87140B (fi) 1992-08-31
JPH0543684B2 (cg-RX-API-DMAC7.html) 1993-07-02
NO873860D0 (no) 1987-09-15
EP0265812B1 (de) 1990-08-08
EG18333A (en) 1993-12-30
MX8958A (es) 1993-12-01
ATE55250T1 (de) 1990-08-15
AU8052987A (en) 1988-05-05
KR900003491B1 (ko) 1990-05-21
KR880004814A (ko) 1988-06-27
AU598602B2 (en) 1990-06-28

Similar Documents

Publication Publication Date Title
EP0498471A3 (en) Liposomes comprising a guanidino aminoglycoside
HU905862D0 (en) Process for producing epy-podophyllotoxin-glycoside-4'phosphate derivatives
GR3002377T3 (en) Ifosfamide-mesna-lyophilized composition and process to prepare it
AU1331588A (en) Method for treatment of alcohol abuse
HUT48266A (en) Process for producing 2,3'-dideoxy-2'-fluoronukleozides and pharmaceutical compositions containing them as active componenets
EP0259139A3 (en) Novel pyridinylpyrimidine derivatives, method for production thereof and a plant disease protectant containing them as the active ingredient
HU900238D0 (en) Process for preparation of 1,4-disubstituted-piperidine-ketone derivatives
YU197387A (en) Process for producing izophamide-liophilizate
GR3004440T3 (cg-RX-API-DMAC7.html)
GR3019973T3 (en) Preparation of substituted tetrahydropyridines
SG40492G (en) Stereospecific process for the preparation of furo(3,4-c)pyridine enantiomers,compounds thus obtained and therapeutical compositions thereof
PT84552A (en) Process for the preparation of a insecticidal composition containing bacterial spores and process for producing the reported spores
HUT45256A (en) Process for producing 1,3,4,9-tetrahydropyrano/3,4-b/indol-1-acetic acid derivatives and pharmaceutical composition containing them
HUT45040A (en) Process for preparing 2,3-dihydrofuran derivatives
GR3001481T3 (en) Preparation of trichlorophenol
GR3003638T3 (cg-RX-API-DMAC7.html)
HU902500D0 (en) Process for producing intermediaries of n,n'-diacyl-aminales
DE3666041D1 (en) Process for preparing 4,5-dihydro-dithienol (3,4b:3'4'-e)-azepin-5,9-dione
EP0422523A3 (en) Process for the preparation of cyclic carbonates
EP0173753A4 (en) 6-SUBSTITUTED PROSTAGLANDINE E 1 AND THEIR PRODUCTION.
HUT46693A (en) Process for producing dioxabicyclo/3,3,0/oktanon-oxim-ethers and pharmaceutical compositions containing them as active components
AU589100B2 (en) Process for the preparation of N,N'-tetrathiodimorpholine
EP0415564A3 (en) Improvement of excretion of nonprotein nitrogen into the intestine by prostanoic acid derivaties
CS286788A1 (en) Method of 2, 3 to 4, 6-diisopropylidene-2-keto-l-gulonic acid preparation
GR3003320T3 (en) Process for the preparation of 5-hydroxydipraphenone and its salts with acids